Table 2.
Study instruments.
| Baseline (T0) | Post-intervention (T1) | |
|---|---|---|
| Demographics | x | |
| Clinical treatment regime | x | x |
| Blood samples | Before and after MBGT session 1 & 4* | |
| Empathy Quotient (EQ) | x | x |
| Interpersonal Reactivity Index (IRI) | x | x |
| Personal and Social Performance Scale (PSP) | x | x |
| Positive and Negative Syndrome Scale (PANSS) | x | x |
| Self-Evaluation of Negative Symptoms (SNS) | x | x |
| Depression Anxiety Stress Scale (DASS) | x | x |
| Southampton Mindfulness Questionnaire (SMQ) | x | x |
| Cognitive Fusion Questionnaire (CFQ) | x | x |
| Adverse events (AE) and serious adverse events (SAE) | x | |
Note.
⁎
In the MBGT + TAU group, blood samples were collected both before and after the initial and final MBGT sessions, resulting in a total of four samples. In the TAU group, two samples were obtained, aligning with the first and last time-points of MBGT + TAU.